Objective Capital Partner’s Channing Hamlet to Address Value of Investment Bankers in Company Sale Transaction

Posted September 26, 2016 by OCP | Post a Comment

San Diego, CA – September 27, 2016- Objective Capital Partners, a leading M&A investment banking firm focused on transactions for companies with enterprise values up to $500 million, is pleased to announce that Channing Hamlet, one of its Managing Directors, will be a guest panelist speaker at the Association for Corporate Growth (ACG) San Diego meeting to be held on Tuesday, October 18, 2016.  Mr. Hamlet will be joined by fellow panelists Steve Moon, Managing Director of Duff & Phelps Securities, John Henberger, Jr., President of Henberger Group and Jeremiah Mann, Managing Director of Intrepid Investment Bankers.  The panel will be moderated by Bill Lynch, VP of ProFinance, and will address the important topic of How Investment Bankers Increase Company Sale Value. A separate breakout session will be conducted after the program specifically for C-Level executives and business owners to allow them to ask questions of the panelists and speakers. The event is sponsored by BDO, Procopio and Vantage Point and will be held at Lomas Santa Fe Country Club in Solana Beach, CA from 7-9 AM. Breakfast is provided with registration for the event.

(more…)

Business Valuation, Press News, Buy-Side M&A, Sell-Side M&A

Manage Your Business to Achieve Maximum Price When You Sell

Posted September 22, 2016 by OCP | Post a Comment

By Channing Hamlet
Managing Director, Objective Capital Partners

For business owners to truly assess the potential value of their business, they must first understand what drives business value in their industry. While at a very high level one can use metrics like Enterprise Value (EV)/Revenue or Enterprise Value (EV)/ EBITDA multiples to assess rough hypothetical values, the reality is that each industry has a unique valuation metric that is used to assess businesses that operate in a particular space or sector. Additionally, there are a number of factors besides just growth and profitability that drive significant value.

Successful business owners and leaders create, understand and track specific metrics that increase the value of their business. This article was written to assist you in defining the things to think about in order to manage and grow the value of your business.

(more…)

Business Valuation, Blog Article, Sell-Side M&A

It’s All About the Exit -A Fireside Chat With Bob Nascenzi and Objective Capital’s Trever Acers

Posted September 13, 2016 by OCP | Post a Comment

San Diego, CA – September 14, 2016- Objective Capital Partners is pleased to announce that Trever Acers, one of its Managing Directors, will be a guest speaker in a fireside chat alongside Bob Nascenzi to address important topics in the exit of a business on October 5, 2016.  The event is sponsored by MIT Enterprise Forum San Diego and will be held a National University, Sanford Center in La Jolla, CA from 5-7 PM.  

(more…)

Press News, Buy-Side M&A, Sell-Side M&A

Objective Capital Partners Adds CardioCell to Expanding Portfolio of Life Science Companies

Posted September 07, 2016 by OCP | Post a Comment

Following Positive Results in Phase IIa Heart Failure Clinical Trial,

CardioCell Chooses Objective Capital to Help Manage Rapid Growth

SAN DIEGO – Sept. 7, 2016 – Objective Capital Partners, a leading middle market investment bank and mergers and acquisition (M&A) advisory firm focused on transactions for companies with enterprise values up to $500 million, is pleased to announce that it has recently been retained by CardioCell LLC to help manage its growth needs. CardioCell, a global biotechnology company that uses allogeneic stem cells for cardiovascular indications, recently announced positive data from its Phase IIa clinical trial “Safety and Efficacy of Intravenous Infusion of Ischemia-Tolerant Allogeneic Mesenchymal Stem Cells in Patients With Non-ischemic Cardiomyopathy” at the European Society of Cardiology (ESC) Congress and is currently planning a Phase III study in early 2017.

(more…)

Healthcare, Life Sciences, Press News, Strategic Advisory

Objective Capital Partners Announced as Finalist for 15th Annual M&A Advisor Awards

Posted September 01, 2016 by OCP | Post a Comment

San Diego, CA, September 2, 2016 Objective Capital Partners, a leading middle market Mergers & Acquisition (MA&) advisory firm focused on transactions for companies with enterprise values up to $500 million, has been announced as a finalist for the 15th Annual M&A Advisor Awards.  M&A Advisor recognized Objective Capital Partners’ advisory of Del Mar Recovery Services for the Private Equity Deal of the Year ($25-50MM) award category. Objective Capital served as exclusive financial advisor to Del Mar in its recapitalization with the private equity firm TZP Growth Partners in July 2016.

(more…)

Awards

This article is provided for informational purposes only and does not constitute an offer, invitation or recommendation to buy, sell, subscribe for or issue any securities. While the information provided herein is believed to be accurate and reliable, Objective Capital Partners and BA Securities, LLC makes no representations or warranties, expressed or implied, as to the accuracy or completeness of such information. It should not be construed as investment, legal, or tax advice and may not be reproduced or distributed to any person.

Our Services

Learn about our services and how we can help you sell your business successfully.

LEARN MORE

Contact Us

San Diego Office:
3636 Nobel Dr., Suite 160
San Diego, CA 92122

Los Angeles Office:
10100 Santa Monica Blvd., Suite 300
Los Angeles, CA 90067

Trever Acers
Managing Director
858.663.8662 telephone
trever.acers@objectivecp.com

Channing Hamlet
Managing Director
858.342.4939 telephone
channing.hamlet@objectivecp.com

David H. Crean, Ph.D.
Managing Director
858.461.9490 telephone
david.crean@objectivecp.com

Jack J. Florio
Managing Director
858.864.4339 telephone
jack.florio@objectivecp.com